Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Up 0.4% – Should You Buy?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)’s share price was up 0.4% during mid-day trading on Friday . The company traded as high as $10.65 and last traded at $10.65. Approximately 225,508 shares were traded during mid-day trading, an increase of 586% from the average daily volume of 32,893 shares. The stock had previously closed at $10.61.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Trading Up 0.4%

The company’s fifty day moving average is $10.61 and its 200-day moving average is $10.54.

Hedge Funds Weigh In On Oaktree Acquisition Corp. III Life Sciences

Large investors have recently bought and sold shares of the business. Lighthouse Investment Partners LLC increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 88.9% in the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock valued at $8,882,000 after buying an additional 400,000 shares in the last quarter. Goldman Sachs Group Inc. purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the 1st quarter worth $5,417,000. Moore Capital Management LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the second quarter worth $5,502,000. Alberta Investment Management Corp purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the second quarter valued at $5,240,000. Finally, Sculptor Capital LP grew its position in shares of Oaktree Acquisition Corp. III Life Sciences by 100.0% in the second quarter. Sculptor Capital LP now owns 500,000 shares of the company’s stock valued at $5,225,000 after purchasing an additional 250,000 shares during the period.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.